GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.4364
-0.0406 (-8.51%)
At close: Jun 5, 2026, 4:00 PM EDT
0.4200
-0.0164 (-3.76%)
After-hours: Jun 5, 2026, 7:56 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $15.74 million as of June 5, 2026. Its market cap has increased by 128.08% in one year.
Market Cap
15.74M
Enterprise Value
6.81M
1-Year Change
128.08%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $15.74M, a decrease of -81.08%. That is a compound annual growth rate of -18.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 15.70M | 89.16% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Passage Bio | 19.25M |
| Exicure | 18.87M |
| Tempest Therapeutics | 18.65M |
| Akari Therapeutics, | 18.13M |
| Quince Therapeutics | 17.93M |
| Lipocine | 17.74M |
| NewcelX | 16.96M |
| Moolec Science | 16.73M |